» Authors » R H A Verhoeven

R H A Verhoeven

Explore the profile of R H A Verhoeven including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 794
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Claassen Y, Dikken J, Hartgrink H, de Steur W, Slingerland M, Verhoeven R, et al.
Eur J Surg Oncol . 2018 Oct; 44(12):1982-1989. PMID: 30343998
Background: As older gastric cancer patients are often excluded from randomized clinical trials, the most appropriate treatment strategy for these patients remains unclear. The current study aimed to gain more...
22.
Brenkman H, van Putten M, Visser E, Verhoeven R, Nieuwenhuijzen G, Slingerland M, et al.
Surg Oncol . 2018 Sep; 27(3):421-427. PMID: 30217297
Background: For patients who qualify for perioperative chemotherapy and gastrectomy for gastric cancer, the optimal timing of the postoperative chemotherapy (PC) seems equivocal. The aim of this study was to...
23.
Hermans T, Voskuilen C, Deelen M, Mertens L, Horenblas S, Meijer R, et al.
Int J Cancer . 2018 Aug; 144(6):1453-1459. PMID: 30155893
In this study, we compared complete pathological downstaging (pCD, ≤(y)pT1N0) and overall survival (OS) in patients with cT2 versus cT3-4aN0M0 UC of the bladder undergoing radical cystectomy (RC) with or...
24.
van Putten M, Nelen S, Lemmens V, Stoot J, Hartgrink H, Gisbertz S, et al.
Br J Surg . 2018 Aug; 105(13):1807-1815. PMID: 30132789
Background: Centralization of surgery has been shown to improve outcomes for oesophageal and pancreatic cancer, and has been implemented for gastric cancer since 2012 in the Netherlands. This study evaluated...
25.
Schroten-Loef C, Verhoeven R, de Hingh I, van de Wouw A, van Laarhoven H, Lemmens V
Eur J Cancer . 2018 Jul; 101:77-86. PMID: 30031970
Background/aim: Unknown primary tumour (UPT) is the term applied to metastatic cancer, the origin of which remains unidentified. Since cancer treatment is primarily based on the tumour site of origin,...
26.
Nelen S, Bosscha K, Lemmens V, Hartgrink H, Verhoeven R, de Wilt J
Br J Surg . 2018 Apr; 105(9):1163-1170. PMID: 29683186
Background: This study investigated age-related differences in surgically treated patients with gastric cancer, and aimed to identify factors associated with outcome. Methods: Data from the Dutch Upper Gastrointestinal Cancer Audit...
27.
Rombouts A, Hugen N, Verhoeven R, Elferink M, Poortmans P, Nagtegaal I, et al.
Eur J Surg Oncol . 2018 Apr; 44(7):1018-1024. PMID: 29678303
Background: In the era of organ preserving strategies in rectal cancer, insight into the efficacy of preoperative therapies is crucial. The goal of the current study was to evaluate and...
28.
van der Graaf W, Tielen R, Bonenkamp J, Lemmens V, Verhoeven R, de Wilt J
Br J Surg . 2018 Apr; 105(8):1020-1027. PMID: 29664995
Background: The incidence, treatment and outcome of patients with newly diagnosed gastrointestinal stromal tumour (GIST) were studied in an era known for advances in diagnosis and treatment. Methods: Nationwide population-based...
29.
van Putten M, Verhoeven R, Koeter M, van Laarhoven H, van Sandick J, Plukker J, et al.
Ned Tijdschr Geneeskd . 2018 Mar; 162:D1970. PMID: 29600921
Objective: The aim of these studies was to examine the influence of hospital of diagnosis on the probability of receiving curative treatment and its impact on survival among oesophageal and...
30.
van Putten M, de Vos-Geelen J, Nieuwenhuijzen G, Siersema P, Lemmens V, Rosman C, et al.
Eur J Cancer . 2018 Mar; 94:138-147. PMID: 29571082
Background: Treatment for oesophageal cancer has evolved due to developments including the centralisation of surgery and introduction of neoadjuvant treatment. Therefore, this study evaluated trends in stage distribution, treatment and...